BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 3, 2010
View Archived Issues
Pfizer reports on discovery and evaluation of PF-610355 for asthma/COPD
Read More
Alipogene tiparvovec shows safety and efficacy in subjects with LPL deficiency / News in Context
Read More
B7-H4 gene therapy combined with abatacept enhances experimental islet graft survival
Read More
PF-4457845 development and early clinical data reported at recent congresses
Read More
New GHRH receptor antagonists disclosed by sanofi-aventis
Read More
Faxeladol shows comparable safety and efficacy to tramadol in patients with painful polyneuropathy
Read More
E.U. approves Brinavess for rapid conversion of recent-onset AF
Read More
FDA updates Tygacil label to include increased mortality risk
Read More
FDA approves Omnitrope for idiopathic short stature
Read More
Biousian Biotechnology describes new delta-type opioid receptor agonists
Read More
PecFent receives European marketing authorization for breakthrough cancer pain
Read More
Halozyme begins phase II trials of PH-20 in type 1 and type 2 diabetes
Read More
New alpha 2B and 2C adrenoceptor agonists claimed by Allergan
Read More
NIH grants funding to Bionovo for obesity and metabolic syndrome study
Read More
LG Life Sciences discloses new xanthine oxidase inhibitors
Read More
MorphoSys and Absynth partner for MRSA treatments
Read More
Organon and Pharmacopeia claim new TRPV1 ligands
Read More
Eisai initiates phase I study of BAN-2401 in AD
Read More
Orexigen and Takeda to co-commercialize Contrave in North America
Read More
E.C. approves Seroquel XR as add-on treatment for major depressive disorder
Read More
Results reported from study of Cerus' INTERCEPT Blood System
Read More
iBio, Fraunhofer and GE Healthcare to partner for iBioLaunch platform
Read More
NIH awards Celsion grant to develop new oncology treatments
Read More
Ipsen gains rights to fipamezole outside of North America and Japan
Read More
MSD's Sycrest approved in Europe for biopolar disorder
Read More